Ronald King

New research proves pocket-sized, AI-powered ultrasound is a game-changer for urgent care, tackling staff shortages and improving patient outcomes.

Frequency Holdings (OTC: FRQN) plants its flag at 14 Wall Street, a high-stakes play for 'optics and access' amid a volatile market position.

A new report finds offices are less than half full, highlighting a costly problem. AI platforms offer a solution to optimize space and redefine work.

A new webinar explores how integrating data into EHRs is overcoming major barriers to improve mental health outcomes. Learn how this tech revolutionizes care.

A new partnership aims to fill a crucial funding gap for mid-sized businesses with flexible capital, backed by veterans from Oaktree, Sixth Street, and Apollo.

Historic New York firm McLaughlin & Stern launches its first West Coast office by integrating the entire team of respected San Francisco boutique Dillingham & Murphy.

A major milestone in utility management signals a broader corporate shift toward centralized platforms for cost control, efficiency, and sustainability.

Gauzy Ltd. faces potential delisting after recent resignations left its board with zero independent directors, compounding its mounting financial and legal woes.

The biotech celebrates its first FDA drug approval, a massive financial boost, and promising new therapies targeting obesity and Alzheimer's disease.

City Ventures' new solar-powered townhomes are priced below the median, offering a rare, affordable, and sustainable entry into Orange County's tight market.

With nearly three decades of experience, new president Dan Huynn is tasked with transforming Genstone Insurance into a national powerhouse. Here's his plan.

With a massively oversubscribed bond sale and upgraded credit ratings, Italian API giant FIS solidifies its finances to expand in a booming pharma market.

Shareholders to vote on a US$3.65 per share all-cash deal, a significant premium that will take the growing respiratory care provider private.

With a $60M Series A, Chamber Cardio is using AI and risk-sharing to move cardiology to a value-based model, aiming to fix America's costliest disease.

A nationwide study, with NFL legend Steve Gleason as Participant #1, seeks to uncover why high-performance groups face a disproportionate risk of ALS.

Following a major restructuring, FLSmidth appoints Toni Laaksonen as CEO to accelerate growth and capitalize on its new pure-play mining focus.

South Korean pharma giant Yuyu Pharma invests in James & Ella, the UK's top freeze-dried pet food brand, signaling a major push into the booming pet wellness market.

With $105M in funding and stunning client results, Eudia's 'Augmented Intelligence' is transforming corporate legal from a cost center to a powerhouse.

New data reveals small businesses are leveraging AI-powered PCs to compete with corporate giants, driving a fundamental shift in productivity and strategy.

McCain Foods launches its third 'Farm of the Future' in the UK, showcasing major strides in regenerative agriculture and setting ambitious 2030 climate goals.